Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation - Johanson, J F; Morton, D; Geenen, J; Ueno, R (Am J Gastroenterol, 2008)